24/7 Market News – (NASDAQ: TTNP)  Titan Pharmaceuticals, Inc. Shares are Moving this Morning, up More than 15% on Increasing Volume on News of FDA Clearance.

The stock has more than 1800 trades and is currently trading at .62 The company’s highest trading volume day this year was less than 10 million, with a 52-week high of $2.50.

https://www.prnewswire.com/news-releases/titan-pharmaceuticals-announces-fda-clearance-of-ind-application-for-nalmefene-implant-301580339.html

Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant

SOUTH SAN FRANCISCO, Calif., July 5, 2022 /PRNewswire/ — Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that the U.S. Food and Drug Administration (“FDA”) has cleared its Investigational New Drug (“IND”) application for a Phase 1 study of its six-month or longer subdermal formulation of nalmefene, an opioid antagonist, intended for the prevention of relapse following opioid detoxification in adults with Opioid Use Disorder (“OUD”).